DPS offers a comprehensive range of services to our clients, across different sectors. We have the experience and track record to deliver these services outlined below to meet your project and resourcing needs.
-
SUNY Polytechnic, Silicon Carbide (SiC) Pilot Line
DPS have been engaged to carry out the Basis of Design, the detailed MEP design scope and federated model management with our client.
-
Abbvie, Biologics Cell Culture Suite
DPS was engaged to design a new single use 3,000 SF cell culture suite featuring a fully single-use process pathway after completing the front-end planning phase.
-
AE Manufacturing Equipment Installation Design, Confidential Client
DPS completed the engineering and design phase for the largest private investment manufacturing equipment installation project in the history of the Irish State over a 16 month period.
-
Alexion, Purification Facility Project
Concept, Basic and Detailed Design and CQV for a multi-product single use purification facility housed in a standalone building, with black utilities fed from the existing CUB.
-
Arranta Bio, Microbiome Manufacturing Facility
DPS Group and TRIA provided design services for the renovation and fit-out of a former warehouse space into an 80,000SF cGMP development and manufacturing facility for novel therapies targeting diseases linked to the human microbiome.
-
Avecia, Oligo Manufacturing Facility Expansion
DPS provided detailed design services to assist Avecia in increasing its oligonucleotide API manufacturing capacity with a 20,000SF expansion.
-
BIM, Federated Model Management, Confidential Client
DPS is engaged as to manage the federated model on a 1.2 million sq.ft. solar photovoltaic (PV) manufacturing facility.
-
Biogen, Purification/Harvest (P2P2) & Train 3 Projects
DPS Group successfully secured the C&Q Managed Services Contract for the new Purification / Harvest Suite (P2/H2) and the Train 3 Projects at Biogen Idec, Hillerød, Denmark.
-
BioMarin, Fed Batch Readiness Project
DPS was appointed as the Architectural and Engineering partner for BioMarin’s “Fed Batch Facility Readiness Project”.
-
bluebird bio, Clinical Manufacturing Facility
DPS was retained as the design partner to perform the Concept Design for a cGMP clinical manufacturing facility/Pilot Plant for a CAR-T cell therapy product.
-
BMS, Cell Therapy Facility
The CAR-T Cell Therapy Facility (CTF) project will be a multi-product facility consisting of 4 production and 2 filling suites with supporting utilities labs, offices and logistic facilities with an overall area of ~20,000m².
-
BMS, Hydrogenation Facility
DPS executed full EPCMV project services to deliver a cGMP upgrade to an existing Buss loop technology based Hydrogenation facility in the heart of the BMS facility in Swords.
-
Brammer Bio, Gene Therapy cGMP Manufacturing and QC Operations Facility
DPS provided detailed design services to assist Brammer in developing a new cGMP manufacturing and QC operations facility.
-
Brammer Bio, Viral Vector Manufacturing Facility
Having successfully completed several gene therapy projects, Brammer Bio hired DPS to work on the renovation and expansion of its GMP facility.
-
Capua BioServices, mRNA and Biologics Facility
DPS is executing a feasibility study for Capua BioServices for a manufacturing area that will allow them to enter in to the CDMO market for microbial parenteral biologic substances and mRNA vaccines production.
-
Codiak, Clinical Manufacturing Facility
The goals of this project were to assess current process manufacturing design and capabilities and identify future space and organizational needs.
-
Confidential Client, Lab & HQ Projects
Design of a new Headquarters including BSL2 and BSL3 Laboratories, Offices, Conference Facilities and Catering.
-
Confidential Client, New Production Facility
DPS is implementing new production units in an existing and unused building, in partnership with Talboom
-
Confidential Client, Novel Vaccines Facility
DPS was contracted to develop a pre-concept (feasibility) design for a multi-product mRNA vaccine manufacturing facility, comprising Drug Substance (DNA template and mRNA Synthesis) and Fill Finish.
-
Confidential Client, Oligonucleotide Development Pilot Plant
DPS was engaged to develop a feasibility study to locate an oligonucleotide development and scale up facility at an existing site within the client network.
-
Confidential Solar Manufacturing Client Third Party Commissioning Agent
DPS is engaged as the Owner’s Third Party Commissioning Agent on a 1.2 million sq.ft. solar photovoltaic (PV) manufacturing facility.
-
CSL Behring, Multi-Purpose Biologics Facility (MPF)
CSL plan to build a Multi-Purpose Biologics Facility (MFP) to support their manufacturing strategy; particularly to develop and support growth in gene and cell therapy.
-
ElevateBio, Clinical Manufacturing Facility
DPS was selected to provide professional architectural and engineering services to develop a full design package for ElevateBio’s Massachusetts-based clinical manufacturing facility.
-
Evelo Biosciences, Microbiome Clinical Manufacturing Facility
DPS was engaged by Evelo Biosciences to aid in realizing a new Microbiome Clinical Manufacturing Suite.
-
GSE, HVAC Assistance at Eurogentec
DPS provided on-site HVAC assistance to GSE (general contractor) for the new Eurogentec production building at Seraing.
-
GSK, New Manufacturing Building
Green field cGMP BSL-3 vaccine manufacturing facility. At the end of the detailed design phase, GSK decided to build an integrated team for the Construction and Commissioning phase
-
GSK, Relocation of CLS & ARD Functions
This feasibility aims to move R&D activities (CLS & ARD) from multiple buildings into one integrated R&D building in Rixensart.
-
GSK, Revamping Of A Production Area
Revamping of 1 500 m2 of classified areas dedicated to vials and syringes filling activities in the Building W16 in Wavre.
-
GSK, WN1611 - SQP Cleaning
Detailed Design, Procurement, Construction Management and Qualification services.
-
Homology, Viral Vector Manufacturing Facility & QC Operations
To support its rapid transition into clinical development, the client is planning to build a new cGMP Manufacturing/ Pilot and QC Operations facility.
-
inviCRO, New Laboratories
DPS carried out the architectural and engineering design for a lab fit-out project for inviCRO in Boston, Massachusetts.
-
Janssen Biologics, Single Use Cell Culture Facility
DPS executed the full project engineering design for a new single use Cell Culture Suite at Janssen Biologics site in Cork, Ireland.
-
Janssen, Viral Vector Production Facility
DPS Group developed a concept design for a large scale EMEA viral vector production facility in Sassenheim, the Netherlands.
-
Janssen, VLF Expansion
BSL-2 vaccines production facility expansion for JBV, Leiden to accommodate the production of the COVID-19 vaccines from 2021 on.
-
Lonza Biologics, Multi-product Cell Therapy Manufacturing Suite
Lonza Biologics contracted DPS Group to retrofit an existing manufacturing area to convert the space to a multi-product cell therapy manufacturing suite at its Portsmouth, NH facility.
-
Moderna Therapeutics, Clinical Manufacturing Facility
DPS and TRIA (a DPS Group company) were engaged by Moderna to provide full EPCMV and architectural design services to complete its new 200,000 sf cGMP clinical manufacturing facility in Norwood, MA.
-
Moderna Therapeutics, GMP Manufacturing Facility Retrofit
Moderna is a leader in the development of messenger RNA therapeutics. The company recently acquired a 13,000 sf space to expand their existing operations.
-
MSD, Sterile Manufacturing Facility Upgrade
DPS secured the Concept Study/Basis of Design Studies, Detailed Design and Qualification for the OPS1 Facility upgrade.
-
MSD, New Vaccines Fill Finish Facility
DPS successfully secured the C&Q client led team for the €220m Greenfield vaccines facility at MSD, Carlow, Ireland.
-
MSD, Tissue Culture Boxmeer Expansion
This project allows MSD to expand the Tissue Culture production facility for their Vaccine production operations in Boxmeer the Netherlands.
-
MSD, V116 Project
DPS was awarded the BoD and EPCMV aspects for a major upgrade at MSD, Brinny facility, to provide vaccine production capability with alterations and extensions to a permitted pharmaceutical production building, for pharmaceutical vaccine production use.
-
Mustang Bio, Cell Processing Facility
DPS Group executed full BOD, Detailed Design and Construction Administration for Mustang Bio’s Cell Processing Facility in Worcester, MA.
-
Novartis, Project Next
DPS were engaged to provide the facilities detailed design for Phase 1 of a CAR-T phased manufacturing capacity for Novartis in Stein.
-
Pfizer, COVID Vaccine Readiness Project
To answer the global COVID-19 pandemic Pfizer expanded its Fill & Finish capacity at their site in Puurs. DPS supported Pfizer with multiple sub-projects.
-
Pfizer, Multi-product Kilo Scale API Facility
DPS was awarded the complete architectural and engineering design for a New Products Facility (NPI) at Pfizer, Ringaskiddy site in Cork, Ireland.
-
Pfizer, New Sterile Vaccine Fill Finish Facility
DPS executed engineering, design and procurement for a new 5,000 sq.m vial fill finish facility at Pfizer Puurs, Belgium.
-
Pfizer, Sterile Manufacturing Expansion
DPS was engaged to carry out a Site Master Plan and Concept Study for a new sterile manufacturing expansion for a vial filling and lyophilisation facility.
-
Pfizer, Sterile Manufacturing Facility, Site Master Planning, Spain
DPS were engaged to carry out a Site Master Plan and Feasibility Study for the Pfizer Algete site in Spain for a future sterile manufacturing expansion for a range of product formats;
-
Pfizer, Vaccine Cell 2
The project includes the construction of a new vaccine fill finish facility at Pfizer Puurs.
-
Polypeptide, Engineering Support
Currently providing engineering support by taking care of all phases of several projects from initiation to completion.
-
Replimune, Clinical Manufacturing Facility
DPS was hired to provide engineering and design services for a new cGMP manufacturing facility having completed the process definition and test fit phases.
-
Replimune, Clinical Manufacturing Facility
DPS was hired to provide engineering and design services for a new cGMP manufacturing facility having completed the process definition and test fit phases.
-
Samsung Biologics, Multimodality ATMP Facility
DPS was commissioned to carry out a concept design study for a new Multimodal Production & Development Facility in Song-do, Incheon, South Korea for the manufacture of multi-platform viral vectors, plasmid DNA and monoclonal antibodies.
-
Samsung, mRNA and Plasmid DNA Manufacturing Suite
DPS was commissioned to carry out a feasibility study for a new mRNA and plasmid manufacturing suite in a facility in South Korea.
-
Sangamo Therapeutics, CAR-Treg Clinical Facility
DPS was engaged to develop a feasibility study to assess the opportunity to retrofit an existing building with a CAR-Treg cell therapy clinical manufacturing facility.
-
Sanofi (Genzyme) 31NYA Pilot Plant, MA
Genzyme Biologics R&D is developing an integrated continuous bioprocessing platform for recombinant therapeutic proteins.
-
Sanofi, Biologics Facility Upgrade & Remediation Projects
Sanofi Genzyme’s Allston Landing Facility (ALF) is the main manufacturing facility for Cerezyme, one of the company’s orphan drug products.
-
Sanofi, Clean Utilities Expansion
Construction Supervision & ad-hoc home office support engineering for Sanofi, Geel.
-
Sarepta Therapeutics, Gene Therapy Centre of Excellence and Manufacturing Network
Sarepta, a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, hired DPS to work on numerous projects at both its Massachusetts and Ohio facilities.
-
Semma Therapeutics, R&D and Clinical Manufacturing Facility
DPS completed the MEP Design for the space to accommodate R&D labs and support areas in Semma’s new Cambridge, MA location.
-
Seres Therapeutics, Laboratory and Clinical Manufacturing Facility
This project was a fit-out of approximately 85,000 sf of cGMP pilot plant, laboratory, and office space at 200 Sidney Street in Cambridge, Massachusetts.
-
Solar Program Management US, Confidential Client
DPS is engaged as the Program Manager on a 1.2 million sq.ft. solar photovoltaic (PV) manufacturing facility.
-
SORAA, LED Manufacturing Facility
The project scope is for a new Cleanroom Manufacturing Facility, support and office area of 80,000 sq.ft.
-
UMass MAB, Laboratory, Development and Early Phase Cell Culture Manufacturing Facility, MA
DPS provided full multidisciplinary A/E design for a new, 32,000 sq. ft. biopharmaceutical facility. The greenfield facility in Dartmouth MA, is the anchor tenant of a planned 300-acre biotechnology park.
-
Vertex, Gene / Cell Therapy Manufacturing Facility
DPS was engaged to assist Vertex in determining feasibility to build a multi-product, flexible Gene / Cell Therapy Manufacturing facility in Massachusetts.
-
Vertex, Gene / Cell Therapy Manufacturing Facility
DPS was engaged to assist Vertex in determining feasibility to build a multi-product, flexible Gene / Cell Therapy Manufacturing facility in Massachusetts.
-
Wacker Biotech, mRNA Production & Microbial Process Development Laboratory
Wacker Biotech is a contract manufacturer of therapeutic proteins, vaccines and live microbial products. Their Amsterdam GMP manufacturing facility intends to expand its mRNA production capacity and redesign their process development laboratory.
-
Wafer Fabrication Manufacturing Equipment De-installation, Confidential Client
To facilitate for a major Next Generation 300mm Manufacturing Equipment Installation project for a Confidential Client in Ireland, DPS were engaged to manage and execute the entire Equipment De-installation Program.
-
Wafer Fabrication Manufacturing Equipment Installation, Confidential Client
DPS completed a Wafer Fabrication Manufacturing Equipment Installation project for a confidential client in Ireland over a 24 month period that required a full de-installation, upgrade and reinstallation of next generation process technology.
-
Wafer Fabrication Manufacturing Facility 3D Scanning Project, Confidential Client
DPS completed a Wafer Fabrication Manufacturing Equipment Installation project for a confidential client in Ireland over a 24 month period that required a full de-installation, upgrade and reinstallation of next generation process technology.
-
Wave Life Sciences, Oligonucleotide Production Facility
WAVE Life Sciences wanted a facility to support the process development and clinical manufacturing of their proprietary oligonucleotide products.
-
Zoetis, Drug Substance Scale Up
Zoetis is a global animal health company delivering quality medicines and vaccines, complemented by diagnostic products, genetic tests, biodevices and a range of services.
-
Zoetis, New Fill Finish Building
The project goal was to build a new Fill Finish facility for the Zoetis Louvain-la-Neuve (LLN ) in Belgium to support additional vaccine production.
